Victory Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-17,605
| Closed | -$43K | – | 2812 |
|
|
2020
Q4 | $43K | Sell |
17,605
-202,912
| -92% | -$496K | ﹤0.01% | 2467 |
|
|
2020
Q3 | $695K | Buy |
220,517
+13,937
| +7% | +$43.9K | ﹤0.01% | 1847 |
|
|
2020
Q2 | $601K | Sell |
206,580
-170,652
| -45% | -$496K | ﹤0.01% | 1931 |
|
|
2020
Q1 | $1.06M | Buy |
377,232
+227,043
| +151% | +$640K | ﹤0.01% | 1828 |
|
|
2019
Q4 | $487K | Buy |
150,189
+63,653
| +74% | +$206K | ﹤0.01% | 2024 |
|
|
2019
Q3 | $187K | Buy |
+86,536
| New | +$187K | ﹤0.01% | 2241 |
|
|
2016
Q1 | – | Sell |
-60,949
| Closed | -$216K | – | 1824 |
|
|
2015
Q4 | $216K | Buy |
60,949
+21,516
| +55% | +$76.3K | ﹤0.01% | 1157 |
|
|
2015
Q3 | $198K | Buy |
39,433
+16,837
| +75% | +$84.5K | ﹤0.01% | 1119 |
|
|
2015
Q2 | $145K | Buy |
+22,596
| New | +$145K | ﹤0.01% | 1150 |
|